Register healthcare products centrally in the GCC by SFDA

Central Registration Process for Pharmaceutical Products in the GCC

Course Description

This course provides a comprehensive and practical overview of the Central Registration Process in the Gulf Cooperation Council (GCC), designed for regulatory affairs and pharmaceutical professionals seeking to successfully navigate one of the region’s most important regulatory pathways. The program explains how pharmaceutical products are evaluated, approved, and centrally registered across GCC member states, highlighting regulatory harmonization efforts and country-specific considerations.

Participants will gain in-depth insight into the GCC central registration system, including eligibility criteria, dossier requirements, review procedures, timelines, and post-approval obligations. The course covers the full product life cycle, from dossier preparation and submission through scientific evaluation, committee review, pricing considerations, and marketing authorization issuance. Special attention is given to common regulatory challenges, recent updates, and best practices to ensure efficient approvals and sustained compliance.

Through real-world examples and regulatory case scenarios, learners will develop the knowledge and confidence needed to optimize registration strategies, avoid delays, and ensure alignment with GCC and international regulatory standards.

This section introduces learners to the GCC Data Requirements for Human Drugs Submission (Version 1.1)—the core reference guideline governing pharmaceutical registrations across the GCC region.

You will begin with the fundamentals of a successful submission, including mandatory requirements such as submitting the pharmaceutical product in association with its manufacturing site, as well as the central and country-specific sample submission process, including submissions to the SFDA and other GCC authorities.

Through guided, practical learning, you will explore the standard structure of a pharmaceutical dossier, known as the Common Technical Document (CTD). This section clearly explains how the CTD is organized, the purpose of each module, and what content is required in every module, equipping you with the knowledge and confidence to prepare compliant, high-quality submissions for the GCC market.

In this section, we will guide you step by step through Module 1, providing a comprehensive and practical explanation of every required document. You will learn the acceptance criteria for each document, including whether legalization is required, when a hard copy is mandatory versus when a scanned copy is acceptable, and how to manage missing or incomplete documents at the time of submission—what to do and how to proceed without delaying approval.

This section is enriched with real-world examples from regulatory practice, giving you practical insight into how Module 1 requirements are handled in actual submissions.

Module 1 is a critical component of the CTD, as it is the country-specific module and the primary responsibility of the Regulatory Affairs professional. Mastering this module will equip you with the hands-on knowledge and confidence needed to prepare compliant, submission-ready dossiers for GCC health authorities.

In this section, you will be guided through the Module 2 preparation checklist in a clear and structured way. You will gain a practical understanding of each component of Module 2, supported by detailed explanations and regulatory insights that simplify complex requirements.

As a core part of the Common Technical Document (CTD), this section is designed to help you confidently organize, review, and prepare Module 2, ensuring your submission is complete, compliant, and aligned with regulatory expectations—just as it is done in real regulatory practice.

Module 3 is the most critical component of the Common Technical Document (CTD), as it addresses Quality—the primary area of focus for healthcare authorities. This module serves as the key reference for the analysis of product samples submitted alongside the dossier and plays a decisive role in regulatory approval.

Although Module 3 is typically prepared by global headquarters (HQ), it requires careful review and close regulatory supervision to ensure full compliance with local and regional expectations. In this section, you will explore the Module 3 checklist in detail, gaining a clear understanding of the required documents, their purpose, and how to effectively assess and manage this critical module in real-world regulatory submissions.

This section provides a detailed explanation of Module 4, which covers nonclinical studies, and Module 5, the most critical module related to product safety and clinical evidence. The requirements of Module 5 have driven the emergence of Pharmacovigilance as a dedicated and essential profession within the pharmaceutical industry.

Through this section, students will gain a clear understanding of the structure, purpose, and regulatory expectations of both modules, supported by real-world case studies from regulatory and industry practice that bridge theory with practical application.

This section provides a detailed explanation of Module 4, which covers nonclinical studies, and Module 5, the most critical module related to product safety and clinical evidence. The requirements of Module 5 have driven the emergence of Pharmacovigilance as a dedicated and essential profession within the pharmaceutical industry.

Through this section, students will gain a clear understanding of the structure, purpose, and regulatory expectations of both modules, supported by real-world case studies from regulatory and industry practice that bridge theory with practical application.

This section provides a detailed explanation of Module 4, which covers nonclinical studies, and Module 5, the most critical module related to product safety and clinical evidence. The requirements of Module 5 have driven the emergence of Pharmacovigilance as a dedicated and essential profession within the pharmaceutical industry.

Through this section, students will gain a clear understanding of the structure, purpose, and regulatory expectations of both modules, supported by real-world case studies from regulatory and industry practice that bridge theory with practical application.

This section will guide you through when and how to submit a Marketing Authorization renewal, clearly explaining regulatory timelines, key requirements, and practical steps to ensure a timely, compliant, and successful renewal process.